HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Roberta Costi Selected Research

L870812

7/2008Human immunodeficiency virus type 1 (HIV-1) integration: a potential target for microbicides to prevent cell-free or cell-associated HIV-1 infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Roberta Costi Research Topics

Disease

9Neoplasms (Cancer)
01/2022 - 07/2011
4Infections
10/2021 - 07/2008
3Alzheimer Disease (Alzheimer's Disease)
05/2021 - 10/2012
3HIV Infections (HIV Infection)
03/2018 - 03/2006
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 06/2021
2Squamous Cell Carcinoma of Head and Neck
01/2022 - 06/2021
2Leukemia
10/2019 - 08/2005
1Histoplasmosis
05/2022
1Necrosis
05/2022
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Breast Neoplasms (Breast Cancer)
01/2022
1Carcinoma (Carcinomatosis)
01/2022
1Glioblastoma (Glioblastoma Multiforme)
01/2022
1Neuroblastoma
12/2021
1Fibrosis (Cirrhosis)
10/2021
1Eye Diseases (Eye Disease)
10/2021
1Disease Progression
05/2021
1Dementia (Dementias)
05/2021
1Thrombosis (Thrombus)
01/2021
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2021
1Systemic candidiasis
01/2021
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2021
1Multiple Sclerosis
10/2020
1Leishmaniasis
02/2020
1Visceral Pain
01/2020
1Constipation
01/2020
1Dyspepsia (Indigestion)
01/2020
1Irritable Bowel Syndrome (Syndrome, Irritable Bowel)
01/2020
1Colitis
01/2020
1Neoplasm Metastasis (Metastasis)
12/2018
1Astrocytoma (Pilocytic Astrocytoma)
12/2017
1Cholera
12/2017
1Type 2 Diabetes Mellitus (MODY)
01/2016
1Amyloid Plaque
02/2015
1Acquired Immunodeficiency Syndrome (AIDS)
11/2013
1Chronic Disease (Chronic Diseases)
11/2013

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
01/2016 - 03/2006
3IntegrasesIBA
09/2010 - 03/2006
2Reactive Oxygen Species (Oxygen Radicals)IBA
05/2022 - 02/2015
2Biological ProductsIBA
10/2021 - 01/2021
2CarbamatesIBA
06/2021 - 12/2017
2Antineoplastic Agents (Antineoplastics)IBA
06/2021 - 08/2005
2EnzymesIBA
02/2020 - 03/2006
2Pharmaceutical PreparationsIBA
10/2019 - 03/2018
2heparanaseIBA
12/2018 - 01/2018
1NitrofuransIBA
05/2022
1IndolesIBA
05/2022
1Ergosterol (Lumisterol)IBA
05/2022
1TubulinIBA
01/2022
1KinesinsIBA
01/2022
1Transcription Factors (Transcription Factor)IBA
12/2021
1Aurora Kinase AIBA
12/2021
1Aurora KinasesIBA
12/2021
1PHA 680626IBA
12/2021
1AntimetabolitesIBA
10/2021
1Cyclin B1IBA
06/2021
1EstersIBA
06/2021
1Cholinesterase Inhibitors (Anticholinesterases)IBA
05/2021
1Memantine (Namenda)FDA Link
05/2021
1AntibodiesIBA
01/2021
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2021
1OilsIBA
10/2020
1Cholinergic Agents (Cholinergics)IBA
07/2020
1DeferiproneIBA
07/2020
1trypanothioneIBA
02/2020
1Sulfides (Thioethers)IBA
02/2020
1trypanothione reductaseIBA
02/2020
1Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
02/2020
1tryparedoxin peroxidaseIBA
02/2020
1tryparedoxinIBA
02/2020
1Serotonin (5 Hydroxytryptamine)IBA
01/2020
1NitrogenIBA
01/2020
1tegaserod (Zelnorm)FDA Link
01/2020
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2018
1Sodium Bicarbonate (Baking Soda)FDA LinkGeneric
12/2017
1Human immunodeficiency virus 1 p31 integrase proteinIBA
10/2016
1DisulfidesIBA
01/2016
1ZincIBA
02/2015
1IonsIBA
02/2015
1IronIBA
02/2015
1MetalsIBA
02/2015
1CopperIBA
02/2015
1TransferasesIBA
09/2013
1Amyloid (Amyloid Fibrils)IBA
10/2012
1coactivator-associated arginine methyltransferase 1IBA
07/2011
1Hormones (Hormone)IBA
07/2011
1UC-781IBA
07/2008
1Anti-Infective Agents (Microbicides)IBA
07/2008
1Reverse Transcriptase InhibitorsIBA
07/2008
1AdenineFDA LinkGeneric
07/2008
1NucleotidesIBA
07/2008
1L870812IBA
07/2008
1AcidsIBA
08/2005

Therapy/Procedure

6Therapeutics
01/2022 - 03/2006
1Highly Active Antiretroviral Therapy (HAART)
11/2013